Zentalis Pharmaceuticals(ZNTL)
SAN DIEGO, CAPharmaceutical
Focus: Zentalis Pharmaceuticals is a public biotech company focused on small-molecule oncology therapeutics, headquartered in San Diego with a pipeline spanning solid tumors, hematologic malignancies, and rare cancers.
Profile data last refreshed 14h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
9+2 this month
Stable — net +2 jobs in 30d
5 added, 3 removed. Backfill posture.
Should You Work at Zentalis Pharmaceuticals?
AI assessmentZentalis offers high upside for oncology specialists willing to tolerate acute cash/dilution risk in exchange for near-term Phase 3 catalysts and specialized technical depth.
Why Work Here
- Phase 3 catalyst imminent: Azenosertib dosed first patient in Phase 3 ovarian cancer trial (May 2026), offering near-term clinical validation and potential commercial momentum.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Early-stage
15 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$0K
Pipeline & Clinical Trials
ZN-d5
Healthy VolunteersClinical Trials (1)
NCT04854174A Food Effect Study of ZN-d5 in Healthy Female Volunteers
Phase 1Help build intelligence for Zentalis Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.